Summary:
This is an 18 month study for subjects with mild/early alzheimer's disease.
Qualified Participants Must:
• Be between 50 and 90 years of age
•
Have a reliable partner/caregiver who spends at least 10 hours per week with subject
•
Not need diagnosis of alzheimer's to screen for study
•
Can be taking medications, aricept, exelon or namenda
Qualified Participants May Receive:
If you qualify and sign an informed consent form for a study, you may receive reimbursement for travel and inconvenience for every visit you complete.